CoverMyMeds’ 2025 Medication Access Report: From Barriers to Bridges calls for increased collaboration and interoperability across the healthcare industry to improve patient outcomes.
Report Highlights:
COLUMBUS, Ohio, March 5, 2025 /PRNewswire/ — Patients continue to face medication access and affordability barriers with 65% experiencing delays in receiving their medications and 54% concerned about costs, according to the 2025 Medication Access Report: From Barriers to Bridges published today by CoverMyMeds. Further, one in five patients surveyed modified their prescriptions because they could not afford their medications – and nearly that same number left the pharmacy without their prescription once they learned the prescription would cost more than expected. Click here to access the full report.
Ongoing medication access, affordability and adherence barriers stem from fragmentation among pharmaceutical companies, prescribers, pharmacies and payers, as outlined in the 2025 Medication Access Report. This fragmentation has intensified in recent years due to the rapid pace of industry changes, including the rise in specialty medications, shift in public policy dynamics, integration of artificial intelligence (AI) and the evolving, multidimensional needs of patients. Despite progress, gaps among healthcare stakeholders continue to adversely impact patients, making the need for collaboration and interoperability across the industry more urgent than ever.
“Patients are ultimately the ones shouldering the burden of the barriers that exist between various healthcare organizations playing a part in their care,” said Kevin Kettler, President of CoverMyMeds. “The 2025 Medication Access Report is a call to action, urging us to think differently, collaborate more deeply, and reimagine a healthcare system that puts patients at the center. By working together, we can transform these barriers into bridges and achieve better health outcomes for all.”
Over the last 10 years, CoverMyMeds has analyzed industry statistics, market research, in-depth patient interviews and survey data to shed light on the critical barriers that can limit patients’ access to medications. The annual Medication Access Report is intended to help empower healthcare professionals with actionable strategies to help overcome these challenges. Key insights from this year’s report identify areas of opportunity to meet the multidimensional needs of today’s patients through collaboration and interoperability:
The 2025 Medication Access Report reflects insights gathered by CoverMyMeds over the last 12 months through a combination of proprietary research and extensive analysis of other publicly available sources. Proprietary research spanned 6 phases, including 180 qualitative interviews and 777 quantitative survey responses with pharma companies, pharmacists, providers/prescribers, EHR decision-makers and patients.
To view the full 2025 Medication Access Report, visit go.covermymeds.health/MAR25PR.
About CoverMyMeds
CoverMyMeds, part of McKesson Corporation, is a medication access company committed to helping people get the medicine they need to live healthier lives. Through innovation and collaboration, CoverMyMeds’ solutions seamlessly connect the healthcare network to improve medication access, increase speed to therapy and reduce prescription abandonment. CoverMyMeds’ network includes 350+ electronic health record systems (EHRs), 50,000+ pharmacies, 950,000+ providers and most health plans and PBMs. Visit www.covermymeds.health for more information.
1CoverMyMeds Patient Survey 2023.
22024 Care Access Benchmark Report for Health Plans: Digital Access Insights from a Survey of 1,000 Healthcare Consumers. Kyruus Health, Kyruus, Inc., 2024, www.kyruushealth.com/resources.
SOURCE CoverMyMeds
The Talkdesk Ascend AI platform, through agentic artificial intelligence, gives companies access to advanced multi-channel…
Dustin Plantholt appointed Chief Growth OfficerChris Kurtenbach appointed Chief Operating Officer(Jonathan) Del Lockett appointed Chief…
CARY, N.C., March 17, 2025 /PRNewswire/ -- Fathom Holdings, Inc. (Nasdaq: FTHM) ("Fathom"; or the…
SAN FRANCISCO, March 18, 2025 /PRNewswire/ -- Wonderfeel Biosciences, an industry leader in revolutionary longevity technologies,…
Recipients Personify Excellence in AI, Real-Life Leadership, and Impact across the Greater San Diego Region Winners…
UNIONDALE, N.Y., March 17, 2025 /PRNewswire/ -- PrimeRx, a leading provider of pharmacy management technology,…